In the research conducted by Yan et al. (2019) titled “FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation”, they found FGL2 accelerated tumor progression of GBM by suppressing CD103+ dendritic cell differentiation. Here, FGL2 is linked to neoplasm.